Clinical trials
Active, not recruiting Lymphoma, Non-Hodgkin trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
116 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 6 |
| 2017 | 10 |
| 2018 | 9 |
| 2019 | 10 |
| 2020 | 11 |
| 2021 | 13 |
| 2022 | 15 |
| 2023 | 14 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 116 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 12 |
| Baylor College of Medicine | 10 |
| City of Hope Medical Center | 8 |
| Memorial Sloan Kettering Cancer Center | 8 |
| Genmab | 6 |
| Hoffmann-La Roche | 5 |
| Loxo Oncology, Inc. | 4 |
| St. Jude Children's Research Hospital | 4 |
| AbbVie | 3 |
| Acerta Pharma BV | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 116 |
| Hodgkin Disease | 27 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 25 |
| Lymphoma, Follicular | 24 |
| Lymphoma, Large B-Cell, Diffuse | 24 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 23 |
| Lymphoma | 21 |
| Lymphoma, B-Cell | 21 |
| Lymphoma, Mantle-Cell | 20 |
| Myelodysplastic Syndromes | 16 |
Trials
Showing 1 to 25 of 116. Each trial links to its page on Pharma Observatory.
16 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.